Blaze Bioscience
Home
About Us
Product
For Patients
News
Partnering
Careers
Contact Us
Subscribe for important news releases. You will receive a confirming email.
*
indicates required
Email Address
*
First Name
*
Last Name
*
Organization
Jim Olson discusses Tumor Paint
and Project Violet at TEDx
Press Releases
Blaze Bioscience Announces FDA has Granted Fast Track Designation to BLZ-100 (tozuleristide) for Pediatric Central Nervous System Tumors
April 7, 2020
Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results for Tumor Paint: BLZ-100 (tozuleristide) in Adults with Glioma
May 9, 2019
Blaze Bioscience Announces the Initiation of Pivotal Clinical Trial for Tumor Paint: BLZ-100 (tozuleristide) and the Canvas Imaging System
November 28, 2018
Blaze Bioscience Announces Presentation of Tumor Paint BLZ-100 Clinical Data at Pediatric Neuro-Oncology Basic and Translational Research Conference
June 15, 2017
Blaze Bioscience Announces Presentation of Tumor Paint BLZ-100 Clinical Data at the American Society of Breast Surgeons (ASBrS) Annual Meeting
April 27, 2017
B
laze Bioscience Announces Tumor Paint BLZ-100 Publication in
International Journal of Toxicology
March 28, 2017
Blaze Bioscience Announces Trial in Progress Presentation at ASCO 2016 Annual Meeting
May 31, 2016
Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in
JAMA Otolaryngology Head & Neck Surgery
February 25, 2016
Blaze Bioscience to Present Tumor Paint BLZ-100 at SPIE Photonics West Conference
February 11, 2016
Blaze Bioscience to Present Tumor Paint Clinical Data at 20
th
Annual Society for Neuro-Oncology (SNO) Meeting
November 9, 2015
Blaze Bioscience Announces Presentation at GA
C-SC 2015 Conference
October 27, 2015
Blaze Bioscience Announces Publication of Tumor Paint BLZ-100 Data in
Cancer Research
October 15, 2015
Blaze Bioscience Commences Clinical Trial of BLZ-100 in Patients with Sarcoma Undergoing Surgery
September 22, 2015
Blaze Bioscience Announces Open
Enrollment for Phase 1 Clinical Trial of Tumor Paint BLZ-100 in Patients with Solid Tumor Cancers
July 14, 2015
Blaze Bioscience's
BLZ-100
Receives Orphan Drug Designation from FDA for Brain Cancer
July 7, 2015
Blaze Bioscience Announces Open Enrollment for Phase 1 Clinical Trial of Tumor Paint BLZ-100 in Children with Brain Cancer
June 4, 201
5
Blaze Bioscience An
noun
ces
Poster Presentation at ASCO 2015
Annual Meeting
May 27, 2015
Blaze
Bioscience A
ppoints Jan
Öhrström, M.D., to Its Board of Directors
April 1, 2015
Blaze Bioscience Announces Poster
Presentation
at the American Academy of Dermatology 73rd Ann
ual Meeting
March 18, 2015
Blaze Bioscience Announces NCI
SB
IR
Phase II Funding for Clinical Trial of Tumor PaintTM BLZ-100 in
Sarcoma
October 8, 2014
Blaze Bioscience Anno
unc
es Ini
tiatio
n of
Phase 1
b Brain Cancer
Program
for Tumor Pa
intTM BLZ-100
September 25, 2014
Blaze Bioscience An
nounces Presentation at the 2014 Wedbush PacGrow Life Sciences Managem
ent Access Conference
August 13, 2014
Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100
December 19, 2013
Blaze Bioscience Raises $9 million in Series B Financing
December 3, 2013
Blaze Bioscience and Fred Hutchinson Cancer Research Center Enter into Collaboration and Option Agreement in Support of Optides Discovery Program
July 3, 2013
Blaze Bioscience Announces Two Poster Presentations at AACR-SNMMI Conference and Award of NCI SBIR Contract Advancing Tumor Paint
™
Technology
February 27, 2013
Blaze Bioscience Announces Completion of Series A Financing - Brings Total Investment to $9.8 Million
February 22, 2013
Blaze Bioscience Raises $5.0 Million in Series A Financing
June 8, 2012
Blaze Bioscience Licenses Tumor Paint Technology from
Fred Hutchinson Cancer Research Center
October 18, 2011
Media
Venom Back in Vogue as a Wellspring for Drug Candidates
April 22, 2020
Proceedings of the National Academy of Sciences of the United States of America
Scorpion Venom Could Help to Detect Brain Tumors: Study
May 10, 2019
Newsweek
Novel imaging agent utilizes protein found in scorpion venom
May 10, 2019
Health Imaging
Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas
May 9, 2019
Neurosurgery Now!
Blaze Bio posts phase 1 data for cancer-illuminating 'tumor paint'
May 9, 2019
Fierce Biotech
Seattle startup Blaze Bioscience makes brain tumors ‘light up like a Christmas tree’ in first trial
May 9, 2019
GeekWire
How scorpion venom helps improve brain cancer surgery in children by making tumors glow
February 26, 2019
GeekWire
Blaze Bio Raises $5M to Help Surgeons See Tumors From Healthy Tissue
February 20, 2019
Xconomy
Lighting the Way for Children With Brain Tumors
February 20, 2019
Seattle Children's Hospital
Innovator of the Month: Blaze Bioscience uses scorpion venom to light up cancer tumors
October 5, 2017
Puget Sound Business Journal
What 'Sunday Morning' Didn't Say About How Animals Aid Cancer Research
March 12, 2017
Forbes
On The Horizon: Scorpion venom as cancer treatment
March 12, 2017
CBS Sunday Morning
How Scorpion Venom Is Helping Doctors Treat Cancer
October 19, 2016
Smithsonian.com
Tumor Paint Brings Light to Toddler's Brain Tumor
September 22, 2016
Seattle Children's Hospital
Light at the End of the Scalpel
September 1, 2015
Mosaic Science
Doctors Test Tumor Paint In P
eople
April 8, 2015
NPR Morning Edition
Armed with a
poisonou
s
scorpion and glowing Tumor Paint, Blaze Bioscience takes on cancer
July 9, 20
14
Puget Sound Business Journal
One Doctor's Quest to Save People by Injecting Them With Scorpion Venom
June 24, 2014
WIRED Magazine
Blaze CEO, Heather Franklin, recognized as EY Pacific Region Entrepreneur of the Year Finalist
May 2, 2014
Ernst & Young
2
6 Amazing Startups You Need to Watch in 2014
December 31, 2013
Venture Beat Top Startup List
Treating Kids' Cancer With Science and A Pocket Full of Hope
September 13, 2013
Blaze Co-Founder Dr. Jim Olson Featured on NPR Morning Edition
Why Painting Tumors Could Make Brain Surgeons Better
September 12, 2013
NPR
Blaze Bioscience's brilliant concept in the fight against cancer
September 2012
Seattle Business Magazine
Blaze Co-Founder Dr. Jim Ols
on Featured in P
romotional Video
May 14, 2012
Blaze Bioscience President and CEO
Heather Franklin will speak at Xconomy Forum: Reinventing Biotech’s Business Model
April 3, 2012
Xconomy
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors
October 18, 2011
Xconomy